PMA device
Visian Icl (Implantable Collamer Lens)
STAAR Surgical Company · Lens, Intraocular, Phakic (MTA, Class III) · First FDA decision Dec 22, 2005, newest Nov 14, 2025Nearsightedness and refractive error
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
7
Naming "Visian Icl"
MAUDE reports
286
Brand "Visian Icl", since 2015
PubMed studies
70
Mentioning "Visian Icl"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Visian Icl (Implantable Collamer Lens)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- VISIAN ICL (IMPLANTABLE COLLAMER LENS)PMA supplement
P030016-S048 · Decided Nov 14, 2025 · 273 days after receipt · Normal 180 Day Track
Device type: Lens, intraocular, phakic (MTA) · Ophthalmology
- Visian ICL (Implantable Collamer Lens)PMA supplement
P030016-S036 · Decided Apr 15, 2019 · 164 days after receipt · Normal 180 Day Track No User Fee
Device type: Lens, intraocular, phakic (MTA) · Ophthalmology
- VISIAN ICLPMA supplement
P030016-S019 · Decided May 5, 2011 · 133 days after receipt · Normal 180 Day Track
Device type: Lens, intraocular, phakic (MTA) · Ophthalmology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Visian Icl", any status and sponsor, newest update first.
Staar Surgical CompanyNot on our public-company list
NCT03499821 · 41 participants · Start Mar 20, 2018 · Primary completion Jul 9, 2019
Device: EDOF ICL · For: Presbyopia
Sites: Antwerp, Belgium; Oviedo, Spain; Almería, Spain · 6 sites in all
Staar Surgical CompanyNot on our public-company list
NCT04283149 · 327 participants · Start Jan 30, 2020 · Primary completion Apr 5, 2021
Device: EVO/EVO+ Visian ICL · For: Myopia; Myopic Astigmatism
Sites: Phoenix, Arizona; Honolulu, Hawaii; Indianapolis, Indiana · 14 sites in all
Staar Surgical CompanyNot on our public-company list
NCT04516772 · 125 participants · Start Jul 21, 2020 · Primary completion Dec 11, 2024
Device: Visian TICL · For: Myopic Astigmatism
Sites: Honolulu, Hawaii; Indianapolis, Indiana; Bowie, Maryland · 8 sites in all
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Visian Icl", and for the whole product code for context.
This brand
286 reports: 33 malfunction, 253 injury, 0 death
Whole product code MTA
18,526 reports: 3,641 malfunction, 14,883 injury, 2 death
Newest reports for this brand
9614429-2026-00074 · Received Oct 13, 2026 · Event dated Sep 30, 2026
Device type: Phakic Toric Intraocular Lens (QCB)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
9614429-2026-00067 · Received Oct 1, 2026 · Event dated Sep 30, 2026
Device type: Phakic Toric Intraocular Lens (QCB)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
9614429-2026-00057 · Received Sep 16, 2026
Device type: Lens, Intraocular, Phakic (MTA)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1480-2026 · Started Jan 21, 2026 · Posted by FDA Mar 2, 2026
Reason given: Toric Implantable Collamer for correction/reduction of myopia in phakic eyes with astigmatism were labeled as 12.1 mm length but are 12.6 mm length lenses, so there is the potential for excessive vault, which may cause: Significant reduction of irido-corneal angles, Significant shallowing of anterior chamber, Patient...
Cause as FDA categorized it: Process control · Device type: Phakic Toric Intraocular Lens (QCB)
Z-0464-2024 · Started Sep 29, 2023 · Posted by FDA Dec 1, 2023
Reason given: Their is a potential that intraocular implant devices may not meet specifications.
Cause as FDA categorized it: Software design (manufacturing process) · Device type: Lens, Intraocular, Phakic (MTA)
Z-0465-2024 · Started Sep 29, 2023 · Posted by FDA Dec 1, 2023
Reason given: Their is a potential that intraocular implant devices may not meet specifications.
Cause as FDA categorized it: Software design (manufacturing process) · Device type: Lens, Intraocular, Phakic (MTA)
5 more recall records with a free account
Published research
The most relevant PubMed records for "Visian Icl"[tiab]. The summary above synthesizes these.
- State of refractive surgery with Visian ICL posterior chamber phakic lens in Spain.
Lisa Fernández C, Alió Del Barrio J, Alvarez-Rementería Capelo L, et al. · Arch Soc Esp Oftalmol (Engl Ed) · 2023Multicenter Study
- Intraocular Implantable Collamer Lens with a Central Hole Implantation: Safety, Efficacy, and Patient Outcomes.
Wannapanich T, Kasetsuwan N, Reinprayoon U · Clin Ophthalmol · 2023Review
- The Implantable Collamer Lens with a central port: review of the literature.
Packer M · Clin Ophthalmol · 2018Review
- Comparison of formulas in the implantable collamer lens vault prediction.
Xiong L, Wu J, Du H, et al. · Medicine (Baltimore) · 2023
- Incidence of implantable Collamer lens-induced cataract.
Gimbel HV, LeClair BM, Jabo B, et al. · Can J Ophthalmol · 2018Observational Study
- Visual outcomes of Visian ICL implantation for high myopia in patients with shallow anterior chamber depth.
Niu L, Miao H, Han T, et al. · BMC Ophthalmol · 2019Observational Study
- Phakic Intraocular Collamer Lens (Visian ICL) Implantation for Correction of Myopia in Spectacle-Aversive Special Needs Children.
Tychsen L, Faron N, Hoekel J · Am J Ophthalmol · 2017
- Advanced pigment dispersion glaucoma secondary to phakic intraocular collamer lens implant.
Ye C, Patel CK, Momont AC, et al. · Am J Ophthalmol Case Rep · 2018
- Comparison of the Visian ICL and Verisyse phakic intraocular lenses for myopia from 6.00 to 20.00 diopters.
Boxer Wachler BS, Scruggs RT, Yuen LH, et al. · J Refract Surg · 2009Comparative Study
- Comparison of Implantable Collamer Lens Visian ICL V4 and ICL V4c for high myopia: A cohort study.
Tian Y, Jiang HB, Jiang J, et al. · Medicine (Baltimore) · 2017Comparative Study, Observational Study
- Outcomes after implantable collamer lens surgery in a Canadian cohort.
Chan AT, Zauberman NA, Chan CC, et al. · Can J Ophthalmol · 2017Observational Study
- Mesopic pupil indices as potential risk factors for glare disability after intraocular implantable collamer lens implantation: prospective study.
Xiong J, Xu J, Zhou M, et al. · J Cataract Refract Surg · 2024Observational Study
Other devices of this type
Also filed under product code MTA.
- EVO Visian Implantable Collamer Lens for Myopia (VICMO)STAAR Surgical Company · PMA 2025
- EVO/EVO+ VISIAN® Implantable Collamer® LensesSTAAR Surgical Company · PMA 2022
- Visian Toric ICL (Implantable Collamer Lens)STAAR Surgical Company · PMA 2019
- ARTISAN/Verisyse Myopia Phakic Intraocular Lens (IOL)Ophtec BV · PMA 2018
- Staar Surgical Implantable Collamer Lens (Vision Icl)STAAR Surgical Company · PMA 2017
- Artisan MyopiaOphtec BV · PMA 2024
- EVO/EVO+VISIAN Implantable Collamer LensSTAAR Surgical Company · PMA 2022
- Visian Implantable Collamer LensesSTAAR Surgical Company · PMA 2014
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.